Stratec SE
XETRA:SBS

Watchlist Manager
Stratec SE Logo
Stratec SE
XETRA:SBS
Watchlist
Price: 30.1 EUR 1.18% Market Closed
Market Cap: 366m EUR
Have any thoughts about
Stratec SE?
Write Note

Gross Margin
Stratec SE

27%
Current
28%
Average
47.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
27%
=
Gross Profit
67.8m
/
Revenue
250.5m

Gross Margin Across Competitors

Country DE
Market Cap 365.9m EUR
Gross Margin
27%
Country US
Market Cap 199.4B USD
Gross Margin
56%
Country US
Market Cap 190.5B USD
Gross Margin
67%
Country US
Market Cap 139.9B USD
Gross Margin
64%
Country US
Market Cap 133.6B USD
Gross Margin
69%
Country IE
Market Cap 103.6B USD
Gross Margin
65%
Country US
Market Cap 66B USD
Gross Margin
45%
Country DE
Market Cap 58.1B EUR
Gross Margin
38%
Country US
Market Cap 44.6B USD
Gross Margin
79%
Country CN
Market Cap 313.1B CNY
Gross Margin
64%
Country US
Market Cap 36.3B USD
Gross Margin
41%
No Stocks Found

Stratec SE
Glance View

Market Cap
365.9m EUR
Industry
Health Care

STRATEC SE engages in the design and manufacture of automated analyzer systems in the fields of clinical diagnostic and biotechnology. The company is headquartered in Birkenfeld, Baden-Wuerttemberg and currently employs 1,398 full-time employees. Its business activities are divided into three segments: Instrumentation, which designs and manufactures fully automated analyzer systems for its clinical diagnostics and biotechnology customers; Diatron, which offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications, and Consumables, which develops and sells scientific materials, such as nucleic acid purification and designs and produces smart consumables in the fields of diagnostics, life sciences, and medical technology. In addition, the Company develops workflow software for networking various analyzer systems, as well as develops and sells scientific materials and technologies.

SBS Intrinsic Value
57.34 EUR
Undervaluation 48%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
27%
=
Gross Profit
67.8m
/
Revenue
250.5m
What is the Gross Margin of Stratec SE?

Based on Stratec SE's most recent financial statements, the company has Gross Margin of 27%.